首页> 外国专利> ANTIGENIC DETERMINANTS RECOGNIZED BY ANTI-HUMAN DEATH RECEPTOR DR5 MONOCLONAL ANTIBODY AD5-10, DERIVATIVES AND USES THEREOF

ANTIGENIC DETERMINANTS RECOGNIZED BY ANTI-HUMAN DEATH RECEPTOR DR5 MONOCLONAL ANTIBODY AD5-10, DERIVATIVES AND USES THEREOF

机译:抗人类死亡受体DR5单克隆抗体AD5-10识别的抗原决定簇,衍生物及其用途

摘要

Provided are antigenic determinants recognized by anti-human death receptor DR5 monoclonal antibody AD5-10, derivatives and uses thereof. The antigenic determinants have the amino acid sequence of LITQQDLAPAARA, wherein the core polypeptide is QDLAP. The polypeptides comprising said antigenic determinants can activate the signal pathway downstream of DR5 after binding to monoclonal antibody AD5-10, then result in apoptosis. The antigenic determinants and derivatives thereof can be used for screening and preparing anti-human DR5 agonistic antibody, small molecular compound binding to DR5 and DR5 vaccine. Their nucleotide encoding sequences can be used for preparing antisense nucleotides and small molecular ribonucleotides for treating and preventing tumor and/or AIDS and the like.
机译:提供了抗人死亡受体DR5单克隆抗体AD5-10识别的抗原决定簇,其衍生物和用途。抗原决定簇具有LITQQDLAPAARA的氨基酸序列,其中核心多肽是QDLAP。包含所述抗原决定簇的多肽在与单克隆抗体AD5-10结合后可以激活DR5下游的信号通路,然后导致细胞凋亡。该抗原决定簇及其衍生物可用于筛选和制备抗人DR5激动抗体,与DR5和DR5疫苗结合的小分子化合物。它们的核苷酸编码序列可用于制备反义核苷酸和小分子核糖核苷酸,以治疗和预防肿瘤和/或AIDS等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号